Discussion about this post

User's avatar
Liam Bai's avatar

Very thoughtful – thanks for sharing. When people ask why the biotech markets have been so stagnant, I reflexively say something about interesting rates. But I think that's largely cope and the real reasons are the ones you mention: our target discovery methods are no match for complex disease biology and we're running out of easy targets. Excited for your vision.

Expand full comment
Alex's avatar

Great summary, totally agree! I've been building with this in mind for years.

Expand full comment
1 more comment...

No posts